B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Beta-Alanine

An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported.

300 PubMed studies analyzed · 93 RCTs · Evidence Score: 54.4

Research Domains

Beta-Alanine has been studied across 23 research domains including ⚡ Energy & Fatigue, 🏃 Endurance & VO2, 💪 Strength & Power, 🔬 Inflammation, 🧠 Focus & Attention. The primary research focus is ⚡ Energy & Fatigue with 34% of studies addressing this area.

Loading evidence profile...

This evidence profile for Beta-Alanine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.